financetom
Business
financetom
/
Business
/
MDA Changes Name
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MDA Changes Name
Mar 7, 2024 10:06 AM

12:47 PM EST, 03/07/2024 (MT Newswires) -- MDA Ltd. ( MDALF ) said Thursday that it has rebranded to MDA Space.

"The addition of Space to our brand is a natural evolution. The core of our brand identity is, and always will be, MDA - the three iconic letters that stand for our 55-year heritage, our more than 450 missions, and our record of firsts," Mike Greenley, CEO of MDA Space, said. "Today, MDA is honoured to have the trust of some of the world's biggest players and most innovative companies driving the expansion of the global space economy."

The company's stock slipped 0.03% on last look on Thursday.

Price: 14.98, Change: +0.02, Percent Change: +0.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Huntington Ingalls Industries Insider Sold Shares Worth $4,815,900, According to a Recent SEC Filing
Huntington Ingalls Industries Insider Sold Shares Worth $4,815,900, According to a Recent SEC Filing
Nov 13, 2025
04:38 PM EST, 11/13/2025 (MT Newswires) -- Christopher D Kastner, Director, President & CEO, on November 12, 2025, sold 15,000 shares in Huntington Ingalls Industries ( HII ) for $4,815,900. Following the Form 4 filing with the SEC, Kastner has control over a total of 70,503 common shares of the company, with 2,264 shares held directly and 68,239 controlled indirectly....
United Therapeutics Insider Sold Shares Worth $5,112,335, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $5,112,335, According to a Recent SEC Filing
Nov 13, 2025
04:38 PM EST, 11/13/2025 (MT Newswires) -- Paul A Mahon, Executive Vice President & General Counsel, on November 13, 2025, sold 11,000 shares in United Therapeutics ( UTHR ) for $5,112,335. Following the Form 4 filing with the SEC, Mahon has control over a total of 36,781 common shares of the company, with 36,781 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000123158925000010/xslF345X05/primarydocument.xml...
TSS Q3 Swings to Loss, Revenue Declines
TSS Q3 Swings to Loss, Revenue Declines
Nov 13, 2025
04:39 PM EST, 11/13/2025 (MT Newswires) -- TSS (TSSI) reported a Q3 loss late Thursday of $0.06 per diluted share, swinging from earnings of $0.10 a year earlier. Revenue for the three months ended Sept. 30 was $41.9 million, down from $70.1 million a year earlier. ...
Biopharmaceutical firm VistaGen's fiscal Q2 net loss widens
Biopharmaceutical firm VistaGen's fiscal Q2 net loss widens
Nov 13, 2025
Overview * VistaGen fiscal Q2 net loss widens to $19.4 mln from $13.0 mln year-over-year * R&D expenses increased to $15.9 mln, driven by PALISADE Program costs * Company expects PALISADE-3 Phase 3 trial results by year-end Outlook * VistaGen expects PALISADE-3 trial results by year-end 2025 * PALISADE-4 trial results anticipated in H1 2026 Result Drivers * R&D EXPENSES...
Copyright 2023-2026 - www.financetom.com All Rights Reserved